VCs Facing Longer Timeframes, Higher Hurdles In Med Tech Investments
This article was originally published in The Gray Sheet
Executive Summary
Medical technology start-ups are currently looking at relationships of up to seven years with their venture capital equity partners, up from four or five in the recent past, as the pace of exit opportunities through initial public offerings or merger and acquisition activities has slowed dramatically